Skip to main content
Premium Trial:

Request an Annual Quote

SummerBio, Kyla Partner to Offer Molecular COVID-19 Testing in Bay Area

NEW YORK — SummerBio has partnered with COVID-19 testing provider Kyla to offer PCR-based SARS-CoV-2 testing to people in California's Bay Area, the companies said on Wednesday.

Under the terms of the deal, San Jose-based Kyla will use its fleet of testing vans and clinics in the Bay Area to collect samples, which will be processed by SummerBio at its Menlo Park-based lab, with test results available within 24 hours. Kyla's mobile app will also be used to deliver questionnaires to test recipients, track test results, and provide support.

Insurance will be accepted to cover the cost of testing, but tests will also be offered for $50 each to cash-paying customers.

Additional terms of the arrangement were not disclosed.

"SummerBio has historically offered testing primarily to schools, universities, and other organizations, but with the holiday and travel season approaching, we are excited to partner with Kyla to offer fast turnaround, high-quality PCR testing to individuals in the Bay Area at an affordable price," Sasha Seletsky, SummerBio's chief business officer, said in a statement.

SummerBio, which said it currently processes 100,000 COVID-19 test samples a day, raised $7.3 million in late 2020.

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.